Cancer case puts UniQure’s hemophilia gene therapy on hold, raising alarms,

UniQure, the Belgian drug company leading the race to develop a gene … case of liver cancer in a participant in one of the company’s clinical trials., UniQure, the Belgian drug company leading the race to develop a gene … case of liver cancer in a participant in one of the company’s clinical trials., Read More

Scroll to Top